FluoGuide A/S and LI-COR Biosciences sign agreement to develop uPAR targeted products to guide oncology surgery using LI-COR’s proprietary next-generation fluorophore IRDye 800CW
Copenhagen, Denmark, 13 August 2020 – FluoGuide A/S (“FluoGuide” or “the Company”) has signed a non-exclusive supply and licensing agreement with the US company LI-COR Biosciences. The agreement will help FluoGuide broaden its portfolio of uPAR-targeted products with features unique to IRDye 800CW, such as deep tissue targeting. With this latest agreement, FluoGuide is well-positioned to maximize the clinical and commercial potential of uPAR-targeted products in fluorescent-guided surgery for cancer.FluoGuide’s strategic development plan centers on advancing its lead product, FG001, for